Human immunodeficiency virus type 1 envelope glycoprotein is modified by O-linked oligosaccharides

J Virol. 1994 Jan;68(1):463-8. doi: 10.1128/JVI.68.1.463-468.1994.

Abstract

The human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein has been shown to be extensively modified by N-linked glycosylation; however, the presence of O-linked carbohydrates on the glycoprotein has not been firmly established. We have found that enzymatic deglycosylation of the HIV-1 envelope glycoprotein with neuraminidase and O-glycosidase results in a decrease in the apparent molecular weight of the envelope glycoprotein. This result was observed in both vaccinia virus recombinant-derived envelope glycoproteins and glycoproteins derived from the IIIB, SG3, and HXB2, strains of HIV-1. The decrease in molecular weight was also observed when the envelope glycoprotein had been deglycosylated with N-glycanase F after treatment with neuraminidase and O-glycosidase, indicating that the decrease in apparent molecular weight was not attributable to the removal of N-linked carbohydrate. Treatment with neuraminidase, O-glycosidase, and N-glycanase F was found to be necessary to remove all radiolabel from [3H]glucosamine-labelled envelope glycoprotein, a result seen for both recombinant and HIV-1-derived envelope glycoprotein. [3H]glucosamine-labelled carbohydrates liberated by O-glycosidase treatment were separated by paper chromatography and were found to be of a size consistent with O-linked oligosaccharides. We, therefore, conclude that the HIV-1 envelope glycoprotein is modified by the addition of O-linked carbohydrates.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amidohydrolases / pharmacology
  • Animals
  • Cells, Cultured
  • Chromatography, Paper
  • Gene Products, env / chemistry*
  • Gene Products, env / drug effects
  • Gene Products, env / genetics
  • Glucosamine / metabolism
  • Glycoproteins / chemistry*
  • Glycoproteins / drug effects
  • Glycoproteins / genetics
  • Glycosylation
  • HIV-1 / chemistry*
  • Humans
  • Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase / pharmacology
  • Molecular Weight
  • Neuraminidase / pharmacology
  • Oligosaccharides / chemistry*
  • Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase
  • Polysaccharides / metabolism
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / drug effects

Substances

  • Gene Products, env
  • Glycoproteins
  • Oligosaccharides
  • Polysaccharides
  • Recombinant Proteins
  • Neuraminidase
  • Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase
  • Amidohydrolases
  • Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase
  • Glucosamine